(IMIDAZOL-1-YL-METHYL)-PYRIDAZINE AS NMDA RECEPTOR BLOCKER
申请人:F. HOFFMANN-LA ROCHE AG
公开号:EP1506190B1
公开(公告)日:2006-06-14
US7005432B2
申请人:——
公开号:US7005432B2
公开(公告)日:2006-02-28
Substituted imidazol-pyridazine derivatives
申请人:——
公开号:US20030229096A1
公开(公告)日:2003-12-11
The present invention relates to compounds of formula
1
wherein A is an unsubstituted or substituted cyclic group; and
R is hydrogen or lower alkyl;
or a pharmaceutically acceptable acid addition salt thereof.
These compounds are NMDA NR-2B receptor subtype specific blockers and are useful in the treatment of neurodegeneration, depression and pain.